We serve 1-butyl-3-methylimidazolium hexafluorophosphate CAS:174501-64-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
English Name: 1-butyl-3-methylimidazolium hexafluorophosphate
Synonyms:1-butyl-3-methylimidazol-3-ium,hexafluorophosphate
1-butyl-3-methylimidazolium hexafluorophosphate
1-Butyl-3-methyl-1H-imidazol-3-ium hexafluorophosphate(V)
Molecular Formula: C8H15N2PF6
Molecular Weight: 284.18
CAS No.: 174501-64-5
Purity: 99%
Technical Information
| Appearance: Colorless transparent liquid | Purity: > 99.0 % |
| NMR: Passed | null |
| Solubility: acetonitrile, dichloromethane, etc. | Insolubility: water, ethanol, ethyl acetate, ether, and alkane, |
|
Impurity content: (1) Methylimidazole content: < 1000 ppm; (2) Halogen content: < 1000 ppm; (3) Water content: < 1000 ppm |
|
Physics-Chemistry Properties
| Melting point: -8 ℃ | Decomposition temperature: 390 ℃ |
| Conductivity: 1.49mS/cm | Electrochemical window: 4.6 V |
| Viscosity: 366cP | Density: 1.37 g/cm3 |
Our company has been engaged in the R&D, production of ionic liquids and related technologies for more than ten years. Since 2007, our company has supplied ionic liquid reagents to customers, and can provide customers with ionic liquid products from grams to hundreds of tons. The main product series are: Imidazolium ionic liquids, single-substituted Im ionic liquids, Disubstituted Im ionic liquids, Tri-Substituted Im ionic liquids, Pyrilidinium ionic liquids, Ammonium ionic liquids, Phosphonium ionic liquids, Pyrrolidinium ionic liquids, Piperidinium ionic liquids, Functionized ionic liquids, Vinyl-Based ionic liquids, Hydroxyl-Based ionic liquids, Ether-Based ionic liquids, Ester-Based ionic liquids, Carboxyl-Based ionic liquids, Nitrile-Based ionic liquids, Amido-Based ionic liquids, SulfoAcid-Based ionic liquids, Benzyl-Based ionic liquids, Guanidine-Based ionic liquids, Oxonium salts
Contact us for information like 1-butyl-3-methylimidazolium hexafluorophosphate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Butyl-3-methyl-1H-imidazol-3-ium hexafluorophosphate(V) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-butyl-3-methylimidazol-3-ium,hexafluorophosphate Use and application,1-Butyl-3-methyl-1H-imidazol-3-ium hexafluorophosphate(V) technical grade,usp/ep/jp grade.
Related News: “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylic acid manufacturer “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.[dimethylamino-(2-oxopyridin-1-yl)oxymethylidene]-dimethylazanium,hexafluorophosphate supplier “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.2-Chloro-3-nitro-5-(trifluoromethyl)pyridine vendor Although bird flu poses more of a danger to poultry than humans — it is not easily transmissible among people — the World Health Organization has called on countries to be on guard because the virus can mutate into a transmissible form and has the potential to cause a pandemic.The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.
